Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

$ 10.00

4.8 (115) In stock

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

JPM, Free Full-Text

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels

A Simplified Framework for Workflow in Genetic Testing and Risk

Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes, Hereditary Cancer in Clinical Practice

A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape

Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center

A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing

Disease Spectrum of Breast Cancer Susceptibility Genes

Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version - Siteman Cancer Center